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Introduction {#sec1}
============

HIV envelope glycoprotein (Env) is a homotrimeric transmembrane protein belonging to the class I viral fusion proteins. Binding of Env to host receptor CD4 and coreceptors CCR5 or CXCR4 leads to a cascade of conformational changes and eventually virus entry. Each of the three Env protomers are linked through a membrane-proximal external region (MPER) to a single-pass transmembrane domain (TMD) and an intracellular C-terminal domain (CTD), which play critical roles in fusion ([@bib9], [@bib23], [@bib59]). While several structures of isolated ectodomains, MPER peptides and TMDs have been determined using X-ray crystallography, cryoelectron microscopy (cryo-EM), and nuclear magnetic resonance (NMR), structural studies of the complete Env have been complicated by the challenging nature of the trimer ([@bib9], [@bib74]). Low expression levels and poor long-term stability of native Env, together with structural flexibility and shedding of gp120 subunit ([@bib22]), have led structural biologists to stabilize the trimer with mutations and/or antibodies so as to achieve higher resolution details. Structural intermediates have been captured after receptor binding and in complex with antibodies, which illustrate the intricately coordinated structural transitions of Env ([@bib45], [@bib49], [@bib71]). This flexibility is compounded when parts below the ectodomain are included, so structures of CTD, TMD, and unliganded MPER have only been resolved in isolation using NMR ([@bib11], [@bib15], [@bib39], [@bib67]). In these studies, the MPER is found as a membrane-embedded amphipathic helix and trimeric protrusion from the membrane, the TMD as a three-helix bundle or separate tilted helix, and the CTD as an elongated set of three amphipathic helices, leaving open questions as to how these conformations relate to the full Env trimer assembly. These structures have however provided important insights in the dynamic nature of these domains and show the capacity to adapt to different stages of the entry and fusion process akin to those observed in the ectodomain. Structures of PGT151-antibody-stabilized ectodomains from C-terminally truncated JRFL, BG505, and B41 Env constructs and wild-type, full-length (FL) Env from PC64 and AMC011 donors confirmed the structural similarity to stabilized soluble Env, but due to structural flexibility in micelle-embedded domains, the MPER, TMD, and CTD have remained unresolved ([@bib5], [@bib41], [@bib54], [@bib70]).

A multitude of broadly neutralizing antibodies (bNAbs) have now been characterized, targeting various sites on HIV-1 Env ([@bib24], [@bib63]). Structures of these bNAbs in complex with Env have paved the way for structure-based vaccine design by facilitating the identification of stabilizing mutations that allow large-scale expression and purification of the unliganded ectodomain ([@bib16], [@bib21], [@bib31], [@bib33], [@bib37], [@bib38], [@bib56], [@bib58], [@bib60], [@bib62], [@bib68], [@bib74], [@bib76]). The epitopes of MPER-targeting bNAbs are missing from almost all of these Envs to increase solubility and stability and, therefore, remain the least understood bNAb epitope. Well-known members of the MPER bNAb family are antibodies 10E8 and 4E10, which share common features and high neutralization breadth over different HIV strains ([@bib6], [@bib26], [@bib66], [@bib81]). More recently, a new MPER targeting antibody lineage PGZL1 from donor PG13 and three lineages from donor RV-217 (VRC42, VRC43, and VRC46) with outstanding breadth were discovered. These studies describe in more detail the maturation of MPER-targeting antibodies ([@bib34], [@bib78]). While the mature PGZL1 neutralized 84% of the 130-virus panel with ∼21% heavy chain (HC) and ∼13% light chain (LC) somatic hypermutation (SHM) at the nucleotide level, the recombinant sublineage variant H4K3 (17% HC, 12% LC SHM) was able to neutralize 100% of the panel, and importantly, the germline-reverted variant neutralized 12% of the panel. In RV-217, all three lineages matured with lower SHM (9%--13%) with up to 96% neutralization breadth, whereas the VRC42 lineage reached 50% neutralization breadth with only 2% SHM. These impressive bNAbs, together with the high conservation of MPER sequence, have stimulated renewed interest in MPER-targeting vaccine design and the use of MPER antibodies for post-exposure prophylaxis. Crystal structures of many MPER Fabs have been solved, alone and in complex with MPER peptide and/or with additional short-tailed lipid headgroups ([@bib28], [@bib29], [@bib34], [@bib75], [@bib78]), providing valuable details of MPER peptide and membrane lipid recognition. For example, in the case of 10E8, residues in CDRL1 and CDRH3 were shown to bind to phosphatidic acid and phosphatidylglycerol headgroups. The structure of the most recently discovered MPER antibody, LN01, was resolved in complex with MPER peptide and full TMD, revealing a straight, continuous MPER-TMD helix and a second conformation of the helix with a kink at conserved G691 ([@bib51]). Two intermediate resolution cryo-EM studies of MPER-targeting antibodies (10E8 and PGZL1) in the context of the trimeric ectodomain provide insights into antibody approach angle, steric obstruction by glycans, and antibody-induced lifting of Env from the lipid surface ([@bib41], [@bib78]). Despite efforts to better understand MPER antibodies, the full quaternary epitope has remained elusive, emphasizing the need to study structures of these antibodies in more native environments.

Reconstitution of membrane proteins into lipid nanodiscs in combination with recent advances in cryo-EM has shown great promise as a tool for structural biology of membrane proteins ([@bib13], [@bib17]). This method was made possible by the introduction of apolipoprotein A based scaffold proteins and associated nanodisc assembly methodology in the early 2000s ([@bib1]). Since then several other scaffold types have been introduced, all of which facilitate spontaneous assembly of the target protein into lipid bilayer discs upon detergent removal. In addition to rendering hydrophobic and transmembrane molecules to be essentially as manageable as soluble proteins, the nanodisc technology offers exceptional versatility for experimental design, allowing different disc diameters and lipid compositions to be co-assembled with the target molecule.

In this work, we present approaches to study HIV Env in membranous environments by assembling FL, wild-type Envs from PC64 (clade A) and AMC011 (clade B) donors and a C-terminally truncated BG505 Env (clade A) into detergent-lipid micelles, bicelles, and nanodiscs. In combination with single-particle EM analysis, these protein-lipid assemblies provide tools for studying HIV Env in a lipid bilayer as well as the binding mechanism of MPER bNAbs. In the lipid bilayer systems, MPER bNAbs induce tilting of Env relative to the membrane surface, forming a wedge between the ectodomain and the lipid surface. In addition, by complexing the AMC011FL nanodisc with 10E8 Fab, we were able to characterize the full tripartite quaternary epitope consisting of lipid, peptide, and glycan contacts. Finally, we show that this methodology can be adapted for vaccine engineering by introducing stabilizing mutations into a C-terminally truncated BG505 construct, allowing presentation of the full array of bNAb epitopes, including MPER, without the need for a stabilizing antibody.

Results {#sec2}
=======

Env Incorporation into Detergent-Lipid Micelles, Bicelles, and Nanodiscs {#sec2.1}
------------------------------------------------------------------------

Different assembly pathways were experimentally assessed to establish a modular platform for studying Env and the neutralization mechanism of MPER antibodies in lipid environments ([Figures 1](#fig1){ref-type="fig"} and [S1](#mmc1){ref-type="supplementary-material"}). To build upon the detergent-lipid micelle approach described earlier ([@bib4], [@bib41], [@bib54], [@bib70]), through a more complete detergent removal and addition of scaffold proteins MSP1D1 or peptidisc, Env could be incorporated into bicelles and nanodiscs with various lipid compositions ([Figure 2](#fig2){ref-type="fig"}). In the detergent-lipid micelle approach, lipid molecules are exchanged by partial detergent removal, leading to complexes that are unstable (∼1--2 days) but suitable for high-resolution determination of the ectodomain by cryo-EM. In nanodiscs, a complete detergent removal is done over ∼48 h in the presence of MSP1D1 scaffold protein, leading to a stable lipid bilayer encircled by the scaffold. The peptidisc approach follows the same principles, but the scaffold is now a short, bi-helical, engineered peptide ([@bib7]). In the lipid bicelle approach, similar detergent removal leads to heterogeneously sized bicelles capped by lipid molecules and/or scaffold. Formation of bicelles versus nanodiscs was concluded to be largely dependent on the Env clone. FL PC64 Env (PC64FL) Env preferred the formation of larger bicelle assemblies with multiple Envs compared to AMC011FL, BG505ΔCT, and BG505-ST-710 ([Figures 1](#fig1){ref-type="fig"}B and [S6](#mmc1){ref-type="supplementary-material"}), which predominantly resulted in smaller discs with one or two Envs. We assume this to result from differences in how the hydrophobic TMD and CTD of the different constructs interact with the lipids and scaffold protein during assembly. Nanodisc scaffold MSP1D1 resulted in ∼10-nm-diameter discs, whereas bicelle size is less restricted and varied from ∼15 to ∼25 nm. Therefore, assemblies with a diameter of 10 nm were considered as nanodiscs and larger assemblies as bicelles ([Figures 2](#fig2){ref-type="fig"}B--2D). Selection of lipids also affected the size distribution of the assemblies, although we could not systematically define the effect of lipid composition ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S6). Env occupancy varied from one to two in nanodiscs to between two and four in larger bicelles. Size exclusion chromatography did not efficiently separate the different species, and in most samples, nanodiscs and bicelles were pooled. Different Env occupancies could, however, be easily separated computationally during 2D and 3D classification in EM data processing ([Figure S2](#mmc1){ref-type="supplementary-material"}). Incorporation of lipid molecules was confirmed with mass spectrometry, where five out of seven added lipid types could be confirmed ([Figures S1](#mmc1){ref-type="supplementary-material"}C, S1D, and S1E). The Env incorporation and recovery ratio varied between 5% and 50%. Incorporation was noted to be more efficient and reproducible in smaller, 50- to 100-μL reaction volumes. In control reactions without scaffold protein, less stable proteoliposomes were formed ([Figure S1](#mmc1){ref-type="supplementary-material"}B). In the absence of lipids and scaffold, rosettes of two or more Envs were formed, leading to aggregation after prolonged incubation (∼1--2 days; [Figure S1](#mmc1){ref-type="supplementary-material"}B). PC64FL and AMC011FL Env nanodiscs and bicelles remained intact at +4°C for up to 4 months but could not be recovered after freezing or complete dehydration ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Samples were primarily assessed using negative-stain and cryo-EM single-particle image analysis ([Figure S2](#mmc1){ref-type="supplementary-material"}).Figure 1Preparation of Env Lipid Assemblies(A) Overview of the workflow used to generate and analyze different lipid assemblies.(B) Typical size-exclusion chromatograms of different Env assemblies. 3D reconstructions below the chromatogram peaks illustrate the corresponding forms of the assembly. The lipid bilayer is highlighted in yellow. Incorporation of lipids was confirmed by mass spectrometry from a pool of AMC011 FL nanodiscs and bicelles.See also [Figures S1](#mmc1){ref-type="supplementary-material"}, [S2](#mmc1){ref-type="supplementary-material"}, and [S6](#mmc1){ref-type="supplementary-material"}.Figure 2Comparison of Different Sample Preparation Approaches and Major Components of Sample HeterogeneityStabilizing PGT151 Fab highlighted in blue. Different assembly types are presented with cartoons next to negative stain and cryo-EM 3D reconstructions. The Env ectodomain is highlighted in gray, PGT151 in blue, and the micelle and lipid bilayer in yellow.(A) The ectodomain could be reconstructed to 3--5 Å resolution from all lipid-detergent micelle samples.(B and C) When the whole nanodisc assembly was reconstructed from cryo-EM data, global resolution remained at ∼9 Å, but now the height from the bilayer surface could be measured and is indicated for PC64FL (B) and BG505ΔCT (C). Height was estimated by fitting an Env model to the ectodomain density and a modeled lipid bilayer patch in the EM density corresponding to the disc. The distance between the stable ectodomain ending at Asp664 and the closest atom of the bilayer is reported as the ectodomain height from the bilayer surface. Density that passes through the disc of PC64FL is highlighted in purple.(D) Discs larger than the 10 nm in diameter defined by the MSP1D1 scaffold were considered as bicelles. In these, additional compositional heterogeneity limits the analysis to negative-stain EM reconstructions.(E) Illustrative summary of the cumulative rotational, positional, and compositional heterogeneity indicated by the arrows and shading of Env in different assembly types.See also [Figures S2](#mmc1){ref-type="supplementary-material"}, [S3](#mmc1){ref-type="supplementary-material"}, and [S6](#mmc1){ref-type="supplementary-material"}.

Env Displays Several Degrees of Flexibility in Lipid Assemblies {#sec2.2}
---------------------------------------------------------------

In all detergent-lipid micelle PC64 and AMC011 FL samples, the PGT151-stabilized ectodomain could be reconstructed to 4--5 Å resolution as in our earlier studies ([Figure 2](#fig2){ref-type="fig"}A) ([@bib54], [@bib70]). In the nanodisc sample of BG505ΔCT, the PGT151-stabilized ectodomain was reconstructed to 4.6 Å resolution ([Figure S3](#mmc1){ref-type="supplementary-material"}A), but the global resolution ranged between 9 and 12 Å when disc and regions below the ectodomain were included ([Figure 2](#fig2){ref-type="fig"}B; [Table S1](#mmc1){ref-type="supplementary-material"}). Nonetheless, this resolution enabled positioning of the bilayer surface and measurement of stable part of ectodomain height from the membrane surface (ending at Asp664). In both BG505ΔCT and PC64FL, the ectodomain was 11 Å from the bilayer surface ([Figures 2](#fig2){ref-type="fig"}B and 2C). The PC64FL nanodisc reconstruction at 9 Å resolution contained a continuous density emanating from the bottom of the ectodomain and spanning the bilayer ([Figures 2](#fig2){ref-type="fig"}C and [S3](#mmc1){ref-type="supplementary-material"}B). In bicelles, two to four FL Envs were incorporated, thereby greatly increasing sample heterogeneity and limiting the studies to negative-stain EM analysis ([Figures 1](#fig1){ref-type="fig"}B, [2](#fig2){ref-type="fig"}D, [S2](#mmc1){ref-type="supplementary-material"}A, and [S6](#mmc1){ref-type="supplementary-material"}). In some 2D and 3D classes, bicelle curvature was also observed. In summary, Env assemblies showed several degrees of rotational and positional flexibility as well as compositional heterogeneity in nanodiscs and bicelles, limiting high-resolution structure determination but likely reflecting the native flexibility of the trimer on the surface of membranes ([Figure 2](#fig2){ref-type="fig"}E). Taken that the isolated ectodomain could be reconstructed to higher resolution and that the bilayer was well defined in 2D and 3D classes, we concluded that HR2-MPER region at the intersection of the ectodomain and bilayer is the main contributor to the heterogeneity in the assemblies.

Env-MPER Fab Complexes in Detergent-Lipid Micelles Show Heterogenous Fab Positioning and TMDs Crossing at Residue R696 {#sec2.3}
----------------------------------------------------------------------------------------------------------------------

We next attempted to stabilize the flexible parts of Env and improve the epitope definition by addition of different MPER-targeting antibody Fabs in mixed detergent-lipid micelles ([Figure 3](#fig3){ref-type="fig"}). In all tested combinations of FL Env and MPER Fab, cryo-EM analysis showed no stable, high-resolution structural features for MPER, TMD, or CTD similarly to earlier cryo-EM studies ([Figure 3](#fig3){ref-type="fig"}A) ([@bib41], [@bib54], [@bib70]). One of the tested antibodies involved a variant of 10E8, called 10E8v4-5R+100cF, which was designed to have improved membrane-interaction capacity and showed 10-fold high neutralization potency ([@bib40]). This antibody also failed to show stable, high-resolution structural features, suggesting that stable lipid headgroup contacts are not fully recovered in this approach. Despite collecting large cryo-EM datasets of over 1 million particles, the liganded complexes could not be refined beyond 6--9 Å resolution for the regions below the ectodomain due to structural and compositional heterogeneity. The flexibility was further emphasized with multibody 3D refinement of AMC011FL in complex with one copy of PGZL1 Fab ([Video S1](#mmc2){ref-type="supplementary-material"}), where Fab and micelle show both horizontal and vertical movement in relation to the ectodomain. Similar evidence was provided by superimposition of different Fab occupancy classes from AMC011FL-VRC42.01 dataset showing a continuous Fab position around the micelle ([Figure S4](#mmc1){ref-type="supplementary-material"}A). This positional heterogeneity of Fab, in addition to particle classes without MPER Fab significantly reduced the number of particles in final, stable classes. Regardless of the movement in relation to ectodomain, we were able to detect converging features, namely contacts to the α8-helix of gp41, the N terminus of gp120, proximity of glycans, and the orientation of the HC and LC of the antibody in relation to the ectodomain ([Figure S5](#mmc1){ref-type="supplementary-material"}). By collecting a larger dataset and increasing the particle number of PC64FL in complex with VRC42.01 Fab, a subset of particles could be classified that contained continuous density from HR2 to MPER and into the TMD ([Figure 3](#fig3){ref-type="fig"}B; [Table S1](#mmc1){ref-type="supplementary-material"}). Although the resolution did not enable *de novo* building of an atomic model, fitting in high-resolution structures of the complex components was sufficient to model the MPER and TMD. Interestingly, the individual transmembrane (TM) helices crossed the micelle in a tilted fashion forming an X shape with TMDs from adjacent protomers crossing at an ∼75° angle and at ∼50° in relation to the postulated membrane plane ([Figure 3](#fig3){ref-type="fig"}B). The helices crossed in the micelle at the conserved R696, a residue previously shown to be important for modulating conformational changes of the TMD ([@bib12], [@bib25], [@bib73]).Figure 3Cryo-EM Reconstructions of FL Env-MPER Fab Complexes in Detergent-Lipid Micelles(A) PC64FL and AMC011FL Envs with a panel in of MPER-targeting Fabs showing variable Fab positions and occupancies. The estimated membrane position is indicated as well as the height of the structurally stable part of ectodomain (ending at Asp664) from the membrane surface. Membrane surface position in the absence of the bilayer is estimated based on MPER Fab position. Particle classes with one, two, and three Fabs could be classified from most of the datasets with all showing similar flexibility and heterogenous density in the micelle. When the second or third MPER Fab is not visible, it is bound behind the micelle, pointing away from the viewer.(B) In the complex between PC64FL and VRC42.01 Fab, the MPER density could be followed through to the TMD as continuous density allowing docking of crystal structure of the Fab (PDB: [6MTO](pdb:6MTO){#intref0160}) and NMR structure of TMD helices (PDB: [6B3U](pdb:6B3U){#intref0165}). The position of R696 as the crossing point of the helices is indicated as well as residues R683 and R707 that are commonly positioned at the membrane boundaries.See also [Figures S2](#mmc1){ref-type="supplementary-material"}, [S4](#mmc1){ref-type="supplementary-material"}, and [S5](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}.

Video S1. Multibody Refinement of AMC011FL Detergent-Lipid Micelle in Complex with PGT151 Fab and PGZL1 Fab, Related to Figures 2 and 3Final refinement was used for generating a multibody refinement and principal component analysis of the relative orientations of Env and Fab using Relion 3.0 software. Ten models were generated and combined in sequence in Chimera to illustrate the movement of micelle bound Fab in relation to the Env ectodomain.

EM Analysis of MPER Antibodies Bound to Bicelle- and Nanodisc-Incorporated Env Reveals a Wedging and Tilting Component in the Binding Mechanism {#sec2.4}
-----------------------------------------------------------------------------------------------------------------------------------------------

We next analyzed the MPER antibody-binding mode in lipid bilayer assemblies with varied lipid content. In all tested combinations, addition of the Fab to Env embedded in a lipid bilayer (nanodisc or bicelle) led to displacement of Env to the side of the assembly and tilting of Env in relation to bilayer ([Figures 4](#fig4){ref-type="fig"}, [5](#fig5){ref-type="fig"}, and [S6](#mmc1){ref-type="supplementary-material"}). This suggested that Env tilting is a common phenomenon of MPER antibody binding and prompted us to align the complexes to the bilayer instead of the ectodomain. By comparing the bilayer assemblies to detergent-lipid reconstructions, we also noted that the angle between the ectodomain and the Fab is identical between the two assembly types ([Figure 4](#fig4){ref-type="fig"}B). To confirm the tilting component of MPER binding and further elucidate the tripartite quaternary epitope of the antibody, we then assembled AMC011FL in nanodiscs for cryo-EM analysis with a lipid mixture roughly following the lipid composition previously determined for HIV particles ([@bib44]). We chose to complex the nanodisc with 10E8 Fab, as this is the most characterized MPER-targeting antibody. The complex was frozen on graphene oxide grids to improve particle orientation distribution for cryo-EM analysis. These improvements allowed collection of data with low concentration of sample (∼0.1 mg/mL) and an adequate number of particles to classify stable particle subsets with different Fab occupancies from a relatively small dataset (128,594 particles; [Figures 4](#fig4){ref-type="fig"}C and [S4](#mmc1){ref-type="supplementary-material"}B). Due to steric constraints introduced by the lipid bilayer, 10E8 now showed a fixed position in comparison to the detergent-lipid approach, which in turn improved the 3D classification accuracy of the particles ([Figure S4](#mmc1){ref-type="supplementary-material"}B). When the reconstructions were aligned to a simulated bilayer model, the Env ectodomain with one and two 10E8 Fabs was ∼18 Å away and tilted 110° in relation to the bilayer surface, confirming the tilting observed with bicelles and negative-stain EM data ([Figure 4](#fig4){ref-type="fig"}D), whereas the third Fab led to an ∼10° more vertical Env orientation. The height of the stable part of Env ectodomain from the bilayer surface was now 30 Å compared to ∼18 Å with one or two Fabs ([Figure S4](#mmc1){ref-type="supplementary-material"}C). In PC64FL and BG505ΔCT nanodiscs without MPER Fabs, this distance was 11 Å ([Figures 2](#fig2){ref-type="fig"}B and 2C). The highest global resolution (∼5 Å) was obtained with the complex containing one copy of PGT151 Fab and three copies of 10E8 Fab, which also had the largest number of particles ([Figure 4](#fig4){ref-type="fig"}E). By fitting the crystal structure of 10E8 Fab together with AMC011 Env protomers in the reconstruction, we generated a hybrid model allowing the definition of the tripartite quaternary epitope and an estimate of the contacting residues ([Figure 4](#fig4){ref-type="fig"}E; [Table 1](#tbl1){ref-type="table"}; PDB: [6VPX](pdb:6VPX){#intref0010}). While local resolution estimations showed stabilization of the epitope between Fab A and Env up to 5 Å resolution, the disc, TMD, and CTD were less homogeneous ([Figure 4](#fig4){ref-type="fig"}F). The TMDs were, however, resolved as a continuous density, revealing that the TMDs bound to Fab A and B had straight TMD density tilted at 75° in relation to the bilayer surface. Fab C binding resulted in a TMD tilted at 50°, similar to micelle-embedded TMD in the PC64FL-VRC42.01 Fab complex ([Figures 4](#fig4){ref-type="fig"}G and [3](#fig3){ref-type="fig"}B). The 10E8 Fabs bound to the AMC011FL nanodisc similarly had two distinct binding modes with different binding angles. Fab A and B had a more vertical orientation in relation to the ectodomain than Fab C, which was influenced by the proximal PGT151 ([Figure 4](#fig4){ref-type="fig"}H). Based on fitting of ectodomain and Fab structures in the map, contacts to the ectodomain that were also observed with detergent-lipid micelles ([Figures 3](#fig3){ref-type="fig"} and [S5](#mmc1){ref-type="supplementary-material"}) could now be better defined. Contacts to α8-helix (gp41) and gp120 by CDRH1 and HC framework region 3 (FR3) remained further apart in Fab C compared to Fab A and B ([Figure 4](#fig4){ref-type="fig"}E). As PGT151 does not affect the orientation of 10E8 directly by steric blocking, we assume the differing orientation of Fab C is rather mediated by the stabilization or asymmetric distortion of the protomer-protomer interface induced by PGT151. When fitted positions of 10E8 Fab-MPER peptide crystal structures in the AMC011 nanodisc were compared to ones fitted in the JRFLΔCT micelle complex ([@bib41]), the membrane-surface-facing sides of the MPER peptides were ∼10Å closer to each other ([Figure 4](#fig4){ref-type="fig"}I).Figure 4Analysis of FL Env in Lipid Bicelles and Nanodiscs in Complex with MPER-Targeting Fabs(A) Representative 2D class averages from negative-stain EM data from lipid assemblies of PC64FL and AMC011FL in complex with MPER-targeting antibodies. In all bilayer-assembled Env-MPER antibody complexes, Env was tilted at varying degrees and displaced to the edge of the bilayer. The degree of the Fab binding angle is estimated in relation to the bilayer from the given 2D class average. The lipid bilayer is highlighted in yellow, and MPER Fab is shown in red.(B) Comparison of the VRC42.01 Fab-binding angle in the nanodisc and micelle. The angle between the Fab and the ectodomain was identical, while in the nanodisc, an additional angle can be measured between the bilayer and the Fab. PGT151 Fab is highlighted in blue throughout the figure.(C) Low-pass filtered cryo-EM reconstructions of the AMC011FL nanodisc in complex with 10E8 Fab with different Fab occupancies. The highest resolution and particle count were obtained with the complex containing one copy of PGT151 Fab and three copies of 10E8 Fab, which is used for (E)--(I).(D) Low-pass-filtered reconstructions with one, two, or three copies of 10E8 Fab showing degree of tilting and distance of Env from bilayer in different 10E8 Fab occupancy states.(E) Highest resolution reconstruction and epitopes of the three Fabs with 10E8 Fab crystal structure (PDB: [5T80](pdb:5T80){#intref0170}) docked in. Epitope components are highlighted as indicated in the panel below. The distance from the bilayer surface is also indicated.(F) Local resolution estimation showing up to 5 Å resolution in the ectodomain and stabilized 10E8 Fab epitope.(G) Fab A and Fab C stabilized TMD orientations are highlighted in purple. Residues marking the outer (R683) and inner (R707) bilayer surfaces are highlighted in orange and R696 in blue, which marks the crossing point of TMDs in micelle samples and is now separated. The angles of the two TMDs are estimated in relation to the bilayer surface.(H) Two Fab orientations and dependency of Fab C on the PGT151 position are highlighted in red in low-pass-filtered maps.(I) Comparison of 10E8 Fab docking into the AMC011FL nanodisc and JRFLΔCT micelle reconstructions (EMD-3312) showing an ∼10 Å change in the distance between the MPER peptides (residue Q135 in PDB: [5T80](pdb:5T80){#intref0175}).See also [Figures S2](#mmc1){ref-type="supplementary-material"}, [S4](#mmc1){ref-type="supplementary-material"}, and [S6](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}.Figure 5Assembly of Vaccine Design Adapted BG505-ST-710 into Peptidiscs(A) Examples of BG505-ST-710 peptidiscs with and without the addition of MPER-targeting Fabs as determined from negative-stain EM 2D class averages.(B) Antigenic profiling of BG505-ST-710 peptidiscs compared to equivalent soluble Env (BG505-ST-664) by lectin capture-based biolayer interferometry. The top graph shows binding signals of the indicated Fabs after normalization to the respective PGT121 signal. Exemplary traces of the indicated Fabs are shown below.(C) Antigenicity comparison of AMC011FL in detergent micelles and lipid nanodiscs with protein A-IgG capture mode.See also [Table S1](#mmc1){ref-type="supplementary-material"}.Table 1Contacting Regions between Env and MPER-Targeting Antibody 10E8 Mapped from the Cryo-EM Reconstruction of AMC011FL Nanodisc in Complex with the FabEnv10E8 FabEctodomaingp41 α8-helix (residues 619-622)CDRH1 (25-33)gp120 residues (499-500)HC FR3 (73-77)gp120 N terminusEctodomain-MPERHR2CDRH2 (52-56)MPER peptideCDRH3 (99-100H)Lipids/bilayerCDRL1 (26-30)LC FR3 (67-69)

Assembly of Engineered Env in Peptidiscs {#sec2.5}
----------------------------------------

To overcome the requirement of using antibodies as a purification and stabilization reagent and to adapt our methods for immunogen design purposes, we introduced stabilizing mutations to Env. BG505 Env was engineered with additional mutations (termed SOSIPv5.2) ([@bib69]) and MD39 mutations ([@bib65]) that have previously been demonstrated to increase the stability and expression of soluble trimeric ectodomain of BG505. In addition, the construct was truncated at the C terminus at residue 710 to eliminate unwanted epitopes. This construct was named BG505-ST-710. A soluble version of this construct was generated by further MPER and TMD deletion and named BG505-ST-664. The introduced modifications allowed purification workflows for BG505-ST-710 similar to soluble SOSIP versions and production of unliganded TMD containing trimer. To reduce the introduction of potentially immunogenically active elements from the scaffold protein and improve assembly efficiency, we utilized an apolipoprotein-A1-derived bi-helical peptidisc scaffold ([@bib7]). Assembly with the peptidisc scaffold was also reproducibly more efficient with similar or higher Env occupancy per disc than with MSP1D1. Peptidisc showed similar MPER binding modes as PC64FL and AMC011FL nanodiscs, apart from MPER Fab complex classes, where Env was tilted over the side of the disc, most likely because of the lack of anchoring by CTD, a less restricted scaffold belt formed by the peptidisc scaffold, or the combined effect of both ([Figures 5](#fig5){ref-type="fig"}A and [S6](#mmc1){ref-type="supplementary-material"}). Consequently, this appeared also to allow binding of an additional MPER Fab on the other side of the disc plane as seen in 2D class averages of complexes with DH511.2, PGZL1, and VRC42.01 Fabs ([Figure S6](#mmc1){ref-type="supplementary-material"}). Binding of this construct to a panel of antibodies was tested by biolayer interferometry (BLI; Octet) using lectin-based Env capture ([Figure 5](#fig5){ref-type="fig"}B). Quaternary-specific Fab PGT145, which preferentially binds to correctly folded trimers, bound to Env peptidiscs with binding levels ([Figure 5](#fig5){ref-type="fig"}B) similar to soluble BG505-ST-664. Binding levels of PGT151 to Env peptidiscs were lower compared to the soluble trimer ([Figure 5](#mmc1){ref-type="supplementary-material"}B). Non-neutralizing antibody B6, which binds only to non-native forms of Env, and 39F, which recognizes non-neutralizing epitopes in the V3 loop, showed minimal reactivity to both samples ([Figure 5](#fig5){ref-type="fig"}B). 10E8 bound to Env peptidiscs, but not to BG505-ST-664, which lacks the MPER epitope ([Figure 5](#fig5){ref-type="fig"}B). Taken together, these data confirm that engineered Env peptidiscs are predominantly in native pre-fusion conformations similar to soluble BG505-ST-664 and have the capacity to bind MPER antibodies. To further validate the assembly platform, we compared the antigenicity to AMC011FL in detergent-lipid micelle and nanodisc with DOPC-DOPS-CHS lipid composition. As shown earlier with micelle-embedded AMC011FL, we observed weak binding to VRC01 antibody and clear binding to the quaternary-specific apex-targeting bNAb PGT145 ([@bib70]), indicating that at least a subpopulation of trimers are in a native conformation ([Figure 5](#fig5){ref-type="fig"}C). Binding of non-neutralizing monoclonal antibodies (mAbs) 39F (V3-loop) and B6 (CD4 binding site) was very strong, as expected for wild-type Env proteins in the absence of stabilizing mutations and also in agreement with EM analysis of a similarly prepared nanodisc, where raw data and 2D and 3D class averages showed dissociating trimers and heterogenous Env incorporation into the bilayer ([Figures S3](#mmc1){ref-type="supplementary-material"}, [S4](#mmc1){ref-type="supplementary-material"}, and [S6](#mmc1){ref-type="supplementary-material"}). MPER bNAb 10E8 bound much weaker to the nanodisc than to the micelle, consistent with a more restricted angle of approach imposed by lipid membrane in nanodiscs, whereas membrane-interaction-optimized 10E8v4-5R+100cF showed markedly higher binding to nanodisc as compared to micelle ([Figure 5](#fig5){ref-type="fig"}C).

Discussion {#sec3}
==========

Here, we developed lipid assembly methods and demonstrate that these, in combination with single-particle EM analysis, are well suited to improve our understanding of the structural dynamics of the HIV-1 Env glycoprotein. The system is currently limited to either PGT151-stabilized FL, wild-type constructs or constructs with stabilizing mutations in the ectodomain. In addition, the assemblies are small patches of membrane that may limit the mobility and flexibility of the Env trimer. Nevertheless, the system is a step toward more native environment and open new possibilities for studying Env structure in lipid bilayers by single-particle EM analysis. In addition to controlled lipid composition and the testing new MPER antibodies such as 10E8v4-5R+100cF with improved lipid contacts ([@bib40]), these membrane-embedded Envs may allow structural studies of the effect that CD4 receptor engagement has on the neutralization mechanism of the MPER bNAbs, which thus far has not been possible. As these complexes are likely heterogenous, excellent scalability and the classification power of single-particle EM analysis becomes an important factor in addition to being able to yield high-resolution structural data. Systematic studies of lipid composition, larger macromolecular complexes, and immunization trials will therefore be subjects of future research.

Our studies demonstrate that the ectodomains of membrane-embedded Envs are stable when bound to PGT151 or stabilized with mutations, while the MPER and TMD exhibit a large degree of positional and local structural heterogeneity reflective of local dynamics near the membrane. Large dynamic shifts have also been observed with single-molecule Förster resonance energy transfer (smFRET) studies that suggest at least three distinct conformational states ([@bib45], [@bib47]). In the light of these studies, the flexibility and dynamics we observe in the lipid assemblies may reflect similar spontaneous sampling of functional Env conformations. Recent advances in cryoelectron tomography methods offer another promising approach to study the structures of Env exposed on the virus particle surface. Thus far, these studies have not reached higher than ∼20 Å resolution ([@bib42], [@bib46]) and may be limited by the conformational sampling observed with smFRET measurements and with our lipid assembly system ([Figure 2](#fig2){ref-type="fig"}E). In the lipid systems presented here, structural heterogeneity could be reduced by the addition of MPER Fabs or by incorporation into a nanodisc. Although we did not achieve high enough resolution to build atomic models for MPER, TMD, or CTD, we could extract new details of these typically dynamic domains through 3D classification and by docking high-resolution structures of complex components into the reconstructions.

For the PC64FL micelle in complex with VRC42.01 Fab and the AMC011FL nanodisc with 10E8 Fab, densities likely corresponding to the MPER-bound TMD could be traced through the micelle and nanodisc, respectively. Interestingly, a tilted orientation of TMDs could be determined in micelles with a crossing point at conserved residue R696. Influenza hemagglutinin was shown to have similar TMD dynamics with tilted and straight orientations, suggesting that these could be common type I viral fusion protein TMD topologies ([@bib2]). The arrangement of helices shown here for HIV Env is different than the three-helix bundle topology observed in NMR structures of the TM helices alone ([@bib10], [@bib11], [@bib15], [@bib25], [@bib39]). Thus, the compact three-helix bundle conformation likely represents the low-energy post-fusion conformation of the TMD, and its formation is preferred in the minimal constructs used in the NMR and MD studies. More recently, a similar study of isolated MPER-TMD peptide in nanodiscs supported our conclusions that, in a more native lipid environment, a stable, trimeric topology of the TMD is unfavorable ([@bib73]). Our data in detergent-lipid micelles demonstrate how the ectodomain and MPER restrain the TMD in a crossed topology, which is particularly apparent in the MPER Fab-bound state. This topology of the TMD is consistent with the meta-stable prefusion state primed for the energetically downhill conformational changes associated with post-fusion conformation. In the nanodisc environment, an additional 25° more vertical TMD orientation was observed ([Figure 4](#fig4){ref-type="fig"}G). Strikingly, a similar long, straight MPER-TMD helix was recently shown in a crystal structure of LN01 antibody in complex with complete TMD ([@bib51]). In the nanodisc structure presented here, the R696 TMD crossing point seen in the micelle ([Figure 3](#fig3){ref-type="fig"}B) is now disconnected from other protomers, suggesting that TMD domain coordination is influenced by MPER antibody binding. As compared to the micelle, the nanodisc bilayer introduces additional support for Fab binding, which may result in a more native environment and allow for separation of TMDs in contrast to micelle-embedded complex. The inference is also supported by the difference in position of 10E8 Fab in the AMC011FL nanodisc as compared to the JRFLΔCT micelle, where the membrane-surface-facing side of the docked Fab-MPER peptide structure (PDB: [5T80](pdb:5T80){#intref0015}) is ∼10 Å closer to the adjacent protomer as compared to the nanodisc ([Figure 4](#fig4){ref-type="fig"}I). Therefore, the micelle appears to allow closer juxtaposition of MPER peptides from adjacent protomers when bound to the Fab. Alternatively, the difference in MPER Fab-bound protomer TMD topology could be due to differential effects imposed by the VRC42.01 and 10E8 antibodies.

Our data demonstrate that the MPER is sterically difficult to access and thus support a progressive binding model for MPER antibodies that occurs in series of steps ([Figure 6](#fig6){ref-type="fig"}). Initial contacts of antibody between the Env ectodomain and the lipid surface lead to tilting of Env, which may occur through gradual stabilization of the sampled conformational states. This interaction in turn increases the exposure of the MPER peptide by partially lifting it off from the membrane surface ([Figure 4](#fig4){ref-type="fig"}), lending support that the membrane-embedded and exposed or lifted conformation of the MPER peptide are both relevant for binding ([@bib18], [@bib29], [@bib39]). Binding of additional MPER antibodies may temporarily destabilize the ectodomain and in this way contribute to increased shedding of gp120 shown in an earlier study ([@bib57]). This model would also be in agreement with studies showing increased neutralization efficiency after binding of the CD4 receptor ([@bib32], [@bib55]), which results in a steeper angle of HR2, the helix immediately N-terminal to the MPER ([@bib49]). In the context of the Env clustering on the mature virus particle surface and formation of the entry claw ([@bib8], [@bib64]), the tilting of two Envs away from each other would also inhibit the formation of the entry claw and possibly contribute to the neutralization efficiency. The tilting component could be mechanistically related to the binding of 35O22, another bNAb that targets an epitope at the interface of gp41 and gp120 and similarly binds better after CD4 receptor engagement ([@bib27]). Finally, given the geometry of the three MPERs in trimeric Env, the two Fab arms of an intact immunoglobulin G (IgG) would preferentially bind to two different Env trimers rather than to a single Env spike as seen on the PC64FL bicelle surface with DH511.2 IgG ([Figure S6](#mmc1){ref-type="supplementary-material"}). Given the limitations of the lipid assembly system, the stoichiometry of MPER antibody arms may, however, be different in the biological context where membrane surface is circular and Env is more prone to shed gp120. Second and third antibody arm binding to same trimer on the virus particle may therefore encounter an Env that has already shed gp120 and does not need tilting to access the MPER.Figure 6Model for MPER-Targeting Neutralization Mechanism Steps Based on Lipid Bilayer AssembliesSuggested HR1 (blue), HR2 (orange), MPER (red), and TMD (purple) orientations are presented. Based on the lack of density corresponding to the TMD in our EM reconstructions, we hypothesize that in their ground state, TMDs are fluctuating in a loosely folded scissoring motion. Similarly, native Env spontaneously samples different functional states.(A) In the absence of an MPER-targeting Fab, (1) CD4 triggers stabilization and conformational changes in HR2, MPER and TMD in addition to opening of the ectodomain and exposure of the CCR5 coreceptor binding site. (2) This leads to coreceptor binding and formation of a lower energy state post-fusion conformation of fusion peptide (arrows), HR1, HR2, MPER, and TMD. Further downstream (not represented in this schematic), this extended three-helix bundle undergoes a further condensation into a six-helix bundle and, in concert with adjacent Env molecules, facilitates membrane fusion and viral entry into the host cell.(B) In the MPER-targeting neutralization path (1), approaching antibody forms a wedge between the ectodomain (red arrow) and bilayer surface (blue arrow), tilting the ectodomain, increasing the exposure of MPER peptide, and stabilizing the scissoring of MPER-TMD. While on a planar bilayer, the tilting may restrict access to additional MPER epitopes within the trimer, we observe at least a second MPER-binding event in all tested assemblies. (2) Thus, subsequent Fab arms binding to other protomers may eventually lead to displacement or increased shedding of gp120 in the absence of stabilizing mutations or PGT151 Fab. MPER-TMDs are now separated and locked by the MPER antibody.

The structures with 10E8 yield insight into its mode of binding and possible developmental pathways. As observed in the complex of JRFLΔCT with 10E8 ([@bib41]), our data illustrate that glycans N88 and N625 are positioned to clash with the antibody. These clashes would occur in the proximity of FR3 of the 10E8 HC. FR3 likely also has peptide contacts with gp120 and gp41 ([Table 1](#tbl1){ref-type="table"}) and is a component of 10E8 paratope on the lipid surface and ectodomain. In another study, 10E8 still showed substantial, albeit reduced, neutralization activity when the FRs were reverted closer to the germline sequence ([@bib19]). Importantly, however, these germline revertants had mature CDRs grafted into the constructs and, therefore, the significance of the FRs to early antibody maturation events may have been lost. It is also important to note that framework mutations are shown to be generally required for broad neutralization ([@bib33]). Thus, in light of these studies, our results suggest that immunogens that can drive mutations in FR3 may be important in triggering the maturation of MPER bNAbs.

Most MPER immunogen design efforts have focused on using the MPER peptide in isolation ([@bib43]), largely because of the difficulty in producing FL Env. The critical challenges in using transmembrane Env versions are the low protein production level and instability of the purified transmembrane protein. We achieved ∼100--300 μg total yield per 1 L 293F cells for stabilized BG505-ST-710, which is roughly an order of magnitude away from what would be required for immunization trials in large animal models. Furthermore, compositional heterogeneity could complicate immunogen formulation, although higher Env occupancy per trimer may also be a beneficial factor in immunogen display. With BG505-ST-710, we observed slightly higher compositional heterogeneity as compared to FL Env nanodiscs with one to six Envs per assembly. The combined effect of shorter bi-helical scaffold and the lack of CTD may allow more Envs to be incorporated into single assembly. Likely due to same reasons, upon MPER Fab binding, Env in the peptidisc was displaced over the side of the disc. Nonetheless, with the BG505-ST-710 peptidisc, we were able to display full MPER epitopes in a single, stable molecule. Importantly, we observed the contacts to α8-helix of gp41 in both micelle and nanodisc samples ([Figures 4](#fig4){ref-type="fig"} and [S5](#mmc1){ref-type="supplementary-material"}), indicating that this may be a conserved contact point between MPER antibodies and the ectodomain and a contributor in the tilting component of the neutralization mechanism. The exact structural details should therefore be studied with point mutations in combination with other stabilizing mutations to explore the significance of this contact for antibody binding. In the engineered BG505-ST-710 construct, stabilizing mutations allowed the purification protocol to closely follow the methods standardized for soluble Env, enabling similar structure-based immunogen design approaches as for soluble constructs. Env-nanodisc immunization could address three important open questions in HIV vaccine design. First, the transmembrane version of Env has been shown to possess a glycan shield that is closer to the composition of the glycan shield presented on virus particles ([@bib5], [@bib54], [@bib61], [@bib70]). Second, a recent analysis of the polyclonal immune response against soluble SOSIP immunogen indicated that in the non-human primate model, a dominant response targeted the exposed base of the trimer ([@bib3]). In membrane-embedded formulations, this immunodominant neoepitope would be protected by the bilayer. Additional prevention of off-target immune responses against the scaffold protein can also be minimized with less immunoreactive peptide scaffolds, such as A22 ([@bib35], [@bib36]) and peptidisc ([@bib7]). The third important factor in Env-nanodisc immunization would be the capacity to present the full set of quaternary epitopes, which more closely resemble the corresponding epitopes presented on native virus particles. In summary, our structures enabled examination of the full MPER epitope in a quaternary context ([Figure 4](#fig4){ref-type="fig"}E; [Table 1](#tbl1){ref-type="table"}). These advances will enable future studies of Env in its native, membrane-embedded environment, contributing to immunogen design for an effective HIV vaccine.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Monoclonal anti-HIV-1 Env PGT151-TEV([@bib41])N/AMonoclonal anti-HIV-1 Env PGT121NIH AIDS Reagent Program; <https://www.hiv.lanl.gov/>RRID: [AB_2491041](nif-antibody:AB_2491041){#intref0025}Monoclonal anti-HIV-1 Env DH511.2([@bib75])KY272651.1 (HC); KY272652.1 (LC)Monoclonal anti-HIV-1 Env VRC46.01([@bib34])N/AMonoclonal anti-HIV-1 Env VRC42.01([@bib34])N/AMonoclonal anti-HIV-1 Env VRC42.N1([@bib34])N/AMonoclonal anti-HIV-1 Env 10E8v4_5R+100cF([@bib40])N/AMonoclonal anti-HIV-1 Env PGZL1([@bib78])N/AMonoclonal anti-HIV-1 Env 10E8([@bib26])RRID: [AB_2491067](nif-antibody:AB_2491067){#intref0030}Monoclonal anti-HIV-1 Env PGT145NIH AIDS Reagent Program; <https://www.hiv.lanl.gov/>Cat\#12703; RRID: [AB_2491054](nif-antibody:AB_2491054){#intref0040}Monoclonal anti-HIV-1 Env VRC01NIH AIDS Reagent Program; <https://www.hiv.lanl.gov/>Cat\#12033; RRID: [AB_2491019](nif-antibody:AB_2491019){#intref0050}Monoclonal anti-HIV-1 Env 39FNIH AIDS Reagent Program; <https://www.hiv.lanl.gov/>Cat\#11437**Bacterial and Virus Strains**E. Coli BL21(DE3)Sigma-AldrichCat\#CMC0014**Chemicals, Peptides, and Recombinant Proteins**Peptidisc scaffoldPeptidisc BiotechN/AIsopropyl β-D-1-thiogalactopyranoside (IPTG)Sigma-AldrichCat\#I6758Teknova HBS-P BUFFER PH 7.4Fisher ScientificCat\#NC0804628n-Dodecyl β-D-maltoside (DDM)Sigma-AldrichCat\# D4641CHAPS detergentSigma-AldrichCat\#10810118001Sodium deoxycholate detergentSigma-AldrichCat\#D6750PEI Max transfection reagentPolySciences, IncCat\# 24765-1Triton X-100 detergentSigma-AldrichCat\#11332481001Opti-MEMThermo FisherCat\#3198507018:1 (Δ9-Cis) 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC)Avanti Polar LipidsCat\#85037518:1 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS)Avanti Polar LipidsCat\#84003518:1 (Δ9-Cis) 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE)Avanti Polar LipidsCat\#85072518:1 PA 1,2-dioleoyl-sn-glycero-3-phosphate (DOPA)Avanti Polar LipidsCat\#84087518:1 1,2-dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-4',5′-bisphosphate) (PIP2(4,5))Avanti Polar LipidsCat\#84004618:1 (Δ9-Cis) 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DOPG)Avanti Polar LipidsCat\#840475cholesteryl hemisuccinate (CHS)Sigma-AldrichCat\#C6512Amphipol A8-35AnatraceCat\#A835**Deposited Data**PC64FL + PGT151 Fab + VRC42.01 Fab -- micelle -- cryo-EMThe Electron Microscopy Data BankEMDB-21321AMC011FL + PGT151 Fab + VRC42.01 Fab -- micelle -- cryo-EMThe Electron Microscopy Data BankEMDB-21322PC64FL + PGT151 Fab + VRC42.N1 Fab -- micelle -- cryo-EMThe Electron Microscopy Data BankEMDB-21323PC64FL + PGT151 Fab + DH511.2 Fab -- micelle -- cryo-EMThe Electron Microscopy Data BankEMDB- 21324PC64FL + PGT151 Fab + VRC46.01 Fab -- micelle -- cryo-EMThe Electron Microscopy Data BankEMDB- 21326AMC011FL + PGT151 Fab + PGZL1 Fab -- micelle -- cryo-EMThe Electron Microscopy Data BankEMDB- 21327AMC011FL + PGT151 Fab + 10E8v4-5R 100cF Fab -- micelle -- cryo-EMThe Electron Microscopy Data BankEMDB- 21328BG505delCT + PGT151 Fab -- Nanodisc -- Cryo-EMThe Electron Microscopy Data BankEMDB- 21329BG505delCT (Ectodomain) + PGT151 FabThe Electron Microscopy Data BankEMDB- 21330PC64FL + PGT151 Fab -- Nanodisc -- Cryo-EMThe Electron Microscopy Data BankEMDB-21331AMC011FL + 2 X PGT151 Fab + 1 X 10E8 FabThe Electron Microscopy Data BankEMDB-21332AMC011FL + 2 X PGT151 Fab + 3 X 10E8 FabThe Electron Microscopy Data BankEMDB- 21333AMC011FL + 1 X PGT151 Fab + 2 X 10E8 FabThe Electron Microscopy Data BankEMDB- 21334AMC011FL + 1 X PGT151 Fab + 3 X 10E8 FabThe Electron Microscopy Data BankEMDB- 21335PC64FL - Bicelle -- Negative stain EMThe Electron Microscopy Data BankEMDB- 21336PC64FL + VRC42.01 Fab - Bicelle -- Negative stain EMThe Electron Microscopy Data BankEMDB- 21337PC64FL + DH511.2 Fab - Bicelle -- Negative stain EMThe Electron Microscopy Data BankEMDB- 21338PC64FL + PGT151 Fab - Nanodisc -- Negative stain EMThe Electron Microscopy Data BankEMDB- 21339PC64FL + VRC42.N1 Fab - Bicelle -- Negative stain EMThe Electron Microscopy Data BankEMDB- 21340AMC011FL + VRC42.01 Fab - Nanodisc -- Negative stain EMThe Electron Microscopy Data BankEMDB- 21341AMC011FL + 10E8 Fab - Nanodisc -- Negative stain EMThe Electron Microscopy Data BankEMDB- 21342BG505-ST-710 -- Peptidisc -- Negative stain EMThe Electron Microscopy Data BankEMDB- 21343BG505-ST-710 + 10E8 Fab - Peptidisc -- Negative stain EMThe Electron Microscopy Data BankEMDB- 21344Hybrid model of AMC011FL + 1 X PGT151 Fab + 3 X 10E8 Fab -- Nanodisc -- Cryo-EMProtein Data BankPDB- 6VPX**Experimental Models: Cell Lines**FreeStyle HEK293FThermo FisherCat\#R79007**Recombinant DNA**MSP1D1 scaffold expression plasmid<http://www.addgene.org> ([@bib14])Cat\#20061PC64M18C043-FL (PC64FL) Expression plasmid([@bib82])N/AAMC011FL Expression plasmid([@bib70])N/ABG505ΔCT Expression plasmid([@bib5])N/ABG505-ST-710 DNA Expression plasmidThis paperN/A**Software and Algorithms**Leginon automated image collection software[@bib52]RRID:[SCR_016731](rridsoftware:SCR_016731){#intref0065}DogPicker[@bib72]<https://emg.nysbc.org/redmine/projects/software/wiki/DoGpicker>Relion 3.0[@bib80]RRID:[SCR_016274](rridsoftware:SCR_016274){#intref0075}cryoSPARC2[@bib53]RRID:[SCR_016501](rridsoftware:SCR_016501){#intref0080}MotionCor2[@bib79]RRID:[SCR_016499](rridsoftware:SCR_016499){#intref0085}GCTF[@bib77]SCR_016500Multibody refinement[@bib48]RRID:[SCR_016274](rridsoftware:SCR_016274){#intref0090}CHARMM[@bib30]RRID:[SCR_014892](rridsoftware:SCR_014892){#intref0095}USCF Chimera[@bib20]RRID:[SCR_004097](rridsoftware:SCR_004097){#intref0100}USCF ChimeraX[@bib50]RRID:[SCR_015872](rridsoftware:SCR_015872){#intref0105}GraphPad PrismN/ARRID:[SCR_002798](rridsoftware:SCR_002798){#intref0110}**Other**Superdex 200 increase 10/300 GL columnGE life sciencesCat\#289909440.22 μm PES bottle top filterThermo FisherCat\#596-3320HiTrap protein A columnGE life sciencesCat\#17040301HiTrap KappaSelectGE life sciencesCat\#17545812Biobeads SM-2 ResinBio-RadCat\#1523920Methyl α-D-mannopyranosideSigma-AldrichCat\#M6882Sepharose 4B resinGE life sciencesCat\# 17012001Ni-NTA matrixQIAGENCat\# 30210Protein A Sepharose Fast FlowGE life sciencesCat\#17-0974-01Lentil Lectin Sepharose 4BGE life sciencesCat\#17044401Streptavidin (SA) BiosensorsForteBioCat\#NC9658567Biotinylated Galanthus Nivalis Lectin (GNL)Vector LaboratoriesCat\#B-1245Carbon-coated Cu400 mesh gridElectron Microscopy SciencesCat\#EMS400-CuQuantifoil 1.2/1.3 Holey Carbon GridsElectron Microscopy SciencesQ410CR1.3C-flat grids 1.2/1.3Electron Microscopy SciencesCF413Graphene Oxide on Quantifoil GridsElectron Microscopy SciencesGOQ400R1213

Resource Availability {#sec4.2}
---------------------

### Lead Contact {#sec4.2.1}

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Andrew B. Ward (<andrew@scripps.edu>).

### Materials Availability {#sec4.2.2}

Expression clone BG505-ST-710 is available from the Lead Contact without restriction.

### Data and Code Availability {#sec4.2.3}

3D EM reconstructions have been deposited in the Electron Microscopy Databank (<http://www.emdataresource.org/>) or Protein Databank (<http://www.rcsb.org>) under the accession numbers listed in [Table S1](#mmc1){ref-type="supplementary-material"} and the [Key Resources Table](#sec4.1){ref-type="sec"}.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

HEK293F embryonic kidney cells were cultured in Freestyle 293F expression medium as suspension cell cultures in a humidified incubator at +37°C, supplied with 8% CO^2^. Cells were agitated at 135 rpm.

BL21(DE3) *E. coli* cells were cultured in Luria Broth (LB) medium at +37°C and agitated at 200 rpm.

Method Details {#sec4.4}
--------------

### Recombinant protein expression and purification {#sec4.4.1}

The MSP1D1 scaffold protein was expressed and purified according to standard *E. coli* recombinant protein expression methods using plasmid available at addgene (<https://www.addgene.org>, plasmid \#20061) ([@bib14]). Briefly, BL21(DE3) *E. coli* cells were transfected with plasmid expressing the scaffold and grown to an OD~600~ of ∼0.8. Expression was induced with 1mM IPTG for ∼5 hours. Cells were harvested and MSP1D1 purified by Ni-NTA affinity purification followed by size exclusion using a Superose S6i 10/300 column. The MSP1D1 was used without His-tag cleavage throughout the study. Peptidisc scaffold was purchased from Peptidisc Biotech (<https://peptidisc.com/>).

Env clones PC64M18C043-FL (PC64FL), AMC011FL and BG505ΔCT were purified as described previously ([@bib4], [@bib54], [@bib70]). Briefly, FreeStyle 293F cells (Thermo Fisher \#R79007) cells were transfected with 250 μg of Env DNA per liter of cells and supplemented with 62.5 μg/ml of furin DNA to ensure complete cleavage of Env at cell density of 1.6 milj/ml. Cells were harvested 72 hours post transfection. PGT151 with an engineered TEV site between the Fab and Fc was added on cells prior to lysis with DDM containing buffer. Cleared lysate was mixed with protein A matrix and incubated overnight at +4°C. Next, matrix was washed with 50 mM Tris-HCl (pH 7.4), 300 mM NaCl, 0.1% (w/v) CHAPS, 0.03 mg/mL deoxycholate followed by wash with 50 mM Tris-HCl (pH 7.4), 500 mM NaCl, 0.1% (w/v) DDM, 0.03 mg/mL deoxycholate and finally exchanged to buffer with 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1% (w/v) DDM, 0.03 mg/mL deoxycholate and 2 mM EDTA in gravity flow column. Env was eluted by adding ∼200 μg of TEV enzyme per liter of cell culture used and incubated for 4h at room temperature. Sample was then concentrated and purified with size exclusion chromatography using a Superose S6i 10/300 column.

BG505-ST-710 DNA construct, codon optimized for mammalian cell expression, was subcloned into a pcDNA3.4 expression vector. 293F cells were co-transfected with BG505-ST-710 and furin DNA vectors (500 and 250 μg per 1 L of cells, respectively) using PEI (PolySciences, Inc). The cells were harvested by centrifugation (3,000 RCF, 30 min, 4°C) 48 -- 96 hours post-transfection and lysed using 25 mM Tris + 300 mM NaCl + 1% Triton X-100 buffer (pH 7.4) for 2 hours at 4°C. Cell lysates were cleared by centrifugation (12,000 RCF, 1 hour, 4°C) and subsequent vacuum-filtration (0.22 μm PES filter, Thermo Fisher). Cleared lysates were run over a Sepharose 4B resin (GE Life Sciences) with immobilized PGT145, 2G12 or PGT151 antibodies. BG505-ST-710 was eluted off the column using the elution buffer 25 mM Tris + 3 M MgCl2 + 0.05% DDM + 0.003% DOC (pH 7.2). Sample was concentrated, buffer-exchanged to the gel-filtration buffer 25 mM Tris + 300 mM NaCl + 0.05% DDM + 0.003% deoxycholate and subjected to SEC (Superose S6i 10/300 column).

### IgG and Fab expression and purification {#sec4.4.2}

IgGs and Fabs were expressed following standard protocols as follows. Proteins were expressed in FreeStyle 293F cells (Thermo Fisher \#R79007). About 25 mL Opti-MEM (Thermo Fisher \#31985070) containing ∼750 μg DNA (500 μg heavy chain and 250 μg light chain plasmid) for Fab or ∼500 μg DNA (250 μg heavy chain and 250 μg light chain plasmid) for IgG was mixed with 25 mL Opti-MEM containing 2,250 μg polyethylene imine MAX (MW 40,000; Polyscience - 24765-1). After incubation for 20 min at RT, the transfection mix was added to 1L cells at a density of ∼1.2x106 cells/ml in FreeStyle 293 Expression Medium (Thermo Fisher - 12338018). The cells were incubated at 37°C and 8% CO2 for 6 days. After harvesting the cells, the supernatant, containing IgG or Fab, was filtered and loaded into a HiTrap protein A column (GE Life Sciences \#17040301, for IgG) or HiTrap KappaSelect column (GE Life Sciences \#17545812, for Fab). The column was washed with phosphate buffered saline and eluted with 0.1 M glycine pH 2.7. The fractions were concentrated, and the buffer was changed to 20 mM sodium acetate pH 5.5. The Fab was loaded into a Mono S column and was eluted with a 0 to 60% linear gradient of 1M sodium chloride in 20 mM sodium acetate pH 5.5 buffer. The Fabs were concentrated and stored in 20 mM sodium acetate pH 5.5, PBS or TBS at 4°C or at −80°C.

### Lipid stock preparation {#sec4.4.3}

To ensure reproducibility, all lipid stock solutions were prepared as follows: lipids were either first dissolved in chloroform or, when available, in solvent used from pre-dissolved ampules. Solvent was evaporated for ∼20 minutes under nitrogen gas flow and slow rotation until lipid was deposited as a thin film on the surface of the ampule. Lipids were next re-solubilized into lipid rehydration buffer containing 50 mM Tris (pH 7.4), 150 mM NaCl and 0.1% DDM, and diluted to a final concentration of 1 mM. After 30 min incubation at room temperature, stock solutions were sonicated using stepped micro tip (3 mm), 20 - 25% efficiency and 50% time cycle until the solution was clear (5-30 mins). Stocks were then aliquoted and stored in −80C° until use for up to 6 months. The following lipids were used throughout the study: 18:1 (Δ9-*Cis*) 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 18:1 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS), 18:1 (Δ9-*Cis*) 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 18:1 PA 1,2-dioleoyl-sn-glycero-3-phosphate (DOPA), 18:1 1,2-dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-4',5′-bisphosphate) (PIP2(4,5)), 18:1 (Δ9-*Cis*) 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DOPG), and cholesteryl hemisuccinate (CHS). The lipid mix for disc assembly was prepared by mixing the thawed lipid stocks to final ratio (see assembly below for details), followed by 3 times freeze-thaw cycle with LN2 and room temperature and vortexing between freeze-thaw cycles to ensure even mixing of lipids in DDM micelles.

### Assembly {#sec4.4.4}

An overview of protein purification and assembly workflow is presented in [Figure 1](#fig1){ref-type="fig"}A. Protein concentrations were calculated using absorbance at 280nm and corrected with protein specific extinction coefficient factors. Purified Env was concentrated to ∼1mg/mL using Amicon concentrators with 100 kDa molecular weight cut off (MWCO) prior to mixing with other components. The lipid mixture stock solution was prepared to a total concentration of 1mM. Typical molar ratio for different lipids in the mixture was 40:40:20 (DOPC:DOPS:CHS). MSP1D1 and peptidisc scaffold were diluted to 2mg/mL stocks. Molar ratios of disc assembly components were screened yielding following standard conditions for the assembly mix: 1:8:240 (Env:scaffold:lipid) for MSP1D1 scaffolded discs and bicelles and 1:120:580 for peptidisc. A typical reaction for MSP1D1 scaffolded assemblies consisted of 25 μL of Env, 25 μL of lipids and 10 μL of MSP1D1 scaffold (tot 60 μL) or 25 μL of Env, 50 μL of lipid mix and 25 μL of peptidisc scaffold (100 μL) at concentrations given above. Assembly mixtures were incubated for ∼30 min at room temperature prior to assembly initiation by addition of bio-beads. Prior to use, the bio-beads were rinsed with methanol for ∼1 min followed by three consecutive washes with water (∼10 X vol of the biobeads) and stored at +4C° for up to three days. Approximately 50% vol to total reaction volume of bio-beads was added per assembly reaction. The reaction was incubated for 24-48h at +4°C in a rotating mixer followed by transfer to a new tube with a new batch of bio-beads and additional incubation for 24h to maximize detergent removal. Purification of assembled discs was started by separating aggregated protein by centrifugation for 10 min at 13,000 x r*cf.* at +4°C on a tabletop centrifuge. Discs and bicelles were then subjected to a final polishing purification step either by lentil lectin Sepharose or size exclusion chromatography. Lentil lectin purification was initiated by mixing the assembled discs with TBS equilibrated, drained matrix (Lentil Lectin Sepharose 4B, GE life sciences) in a 1:1 sample-to-matrix ratio. The sample was allowed to bind overnight at +4C°, followed by 3 X washes with ∼1.4ml TBS in a 1.5 mL test tube. Discs were eluted by three consecutive 1h incubations with TBS + 1 M methyl α-D-mannopyranoside using an equivalent volume of elution buffer to matrix (e.g., 100 μL elution buffer per 1h elution from 100 μL of drained lentil lectin matrix). Three fractions were pooled and dialyzed against Env-nanodisc buffer (20 mM Tris-HCl, pH 7.4, 40 mM NaCl) in a 20 kDa MWCO slide-a-lyzer dialysis units (Thermo Fisher Scientific) to remove methyl α-D-mannopyranoside and to prepare the sample for concentration by water evaporation (Savant DNA120 SpeedVac, Fisher Scientific). The sample was concentrated 5 to 10 times the original concentration depending on required protein concentration, resulting in the final sample for EM analysis. If size exclusion chromatography was used as the final polishing step, the Superose S6i 10/300 column was equilibrated in Env-nanodisc buffer and used according to the manufacturer's instructions. Unassembled Env, free scaffold, and lipids were separated, but peaks for different Env occupancies in discs were overlapped too much for separation and were pooled and concentrated as with the lectin purification method. The Env incorporation ratio was measured by calculating the amount of Env added to the assembly reaction versus the concentration in the purified final sample. The stability of disc preparations was assessed by measuring concentration of non-aggregated discs and with EM analysis either after storage in +4°C up to 6 months or by flash freezing in LN2 and storing at −80°C.

### Mass spectrometric identification of lipids {#sec4.4.5}

Nanodisc solution (final 0.12 mg/mL, 40 μL) was digested with proteinase K (2:1, w/w) in TBS ammonium acetate buffer at 4°C for 2h or overnight, and diluted with final 40% (v/v) acetonitrile. Lipid LC MS/MS analyses were performed using an EASY-nLC connected with an LTQ-Orbitrap Velos mass spectrometer (Thermo Fisher). For each run, about 3 μL digest in 40% acetonitrile was directly loaded to a C8 analytical column (Phenomenex C8, bead diameter 5 μm, pore size 100Å, column inner diameter 100 μm, length 20 cm), and eluted with high %B gradients at 0.4 μL/min. LC buffer A was 0.1% formic acid/ 5% acetonitrile/H2O, and buffer B was 0.1% formic acid/ 95% acetonitrile/H2O.

MS instrument settings were adapted to those used for peptide analysis when applicable: spray voltage 2.5 kV and capillary temperature 325°C. CID MS/MS spectra were typically acquired using data-dependent or targeted manner in positive and negative ion modes for precursor m/z range 200-2000. Earlier experiments also acquired MS3 spectra to help confirm lipid identity. Data-dependent MS/MS used a top 10 method, in which one MS scan was followed by MS/MS scans of the top 10 most abundant MS peaks, and were measured by the linear ion trap analyzer using enhanced and normal scan speeds respectively. Ion trap scans had AGC on and used 1 micro scan and max ion injection time of 10 ms; MS/MS used isolation width 2 Th, normalized collision energy 35%, activation Q 0.20 and activation time 20 ms. Dynamic exclusion was applied at 1 Th width for 60 s duration and 2 repeats. The lipid-only vesicle sample formed from the input lipids without protein was used as a reference for lipid identification. Lipid identification was based on fragmentation analysis and comparison of MS and MS/MS spectra with those of the lipid-only vesicle sample and literature.

### Bio-layer interferometry {#sec4.4.6}

Antigenic profiles of Env constructs were measured on an Octet Red 96 instrument (ForteBio) at 23°C in Octet buffer (1x HBS + 3 mM EDTA + 1 mg/mL BSA). Streptavidin (SA) Biosensors (ForteBio) were preincubated with 10 μg/mL biotinylated Galanthus Nivalis Lectin (Vector Laboratories) in Octet buffer for at least 10 minutes. BG505-based Env constructs were captured at 3 μg/mL in Octet buffer for 6 minutes. After a 30 s baseline phase, indicated Fabs were passed over the sensors for 180 s at 200 μg/mL, followed by a 180 s dissociation phase. Lectin sensors were regenerated using three 5 s incubations with 150 mM phosphoric acid. AMC001-based constructs showed lower signal than BG505, and were therefore measured in an inverted format in which IgGs were captured on Protein A chips and nanodiscs or micelles were flowed over the captured IgGs. Data from a matching negative control were subtracted from each curve, Y-axes were aligned to the baseline phase in the Octet Data Analysis software (version 11.0.2.3, ForteBio). Data were exported, normalized to the signal obtained for PGT121, and plotted in Prism for macOS 8.2.1 (Graphpad Software).

### Electron microscopy sample preparation {#sec4.4.7}

Concentrations of final assemblies were estimated using absorbance measurement at 280 nm and extinction coefficient of full-length HIV Env, and verified by negative-stain EM thereby not including the absorbance coming from the scaffold protein. In samples where Env nanodiscs and bicelles were complexed with Fabs for negative-stain EM, three times molar excess of purified Fab fragment per Env trimer was incubated with the Env nanodiscs overnight at +4°C and stained as follows: 3 μL of purified disc preparation at 0.03 -- 0.06 mg/mL was applied to a 400 mesh size Cu grid, blotted off with filter paper, and stained with 2% uranyl formate for 60 s. Cryo-EM grids were prepared differently depending on sample type: for lipid-detergent micelle 10 μL of Env at 5-7 mg/mL was mixed with 1 μL of 1 mM lipid mix and ∼6 times molar excess of Fab, followed by gradual detergent removal and lipid replacement with three consecutive additions of 3-5 bio-beads with 1h incubation on ice between each addition. 3 μL of sample was then applied with 0.5 μL of 0.04% A8-35 amphiphol to either 1.2/1.3 Quantifoil or 1.2/1.3 C-flat grids and flash frozen in liquid ethane using Vitrobot mark IV (Thermo Scientific) without wait time, blot force of 0 and blot time of 6-7 s. PC64FL and BG505ΔCT nanodisc samples were frozen on 1.2/1.3 Quantifoil grids overlaid with in-house made thin carbon film at 0.1 -- 0.5 mg/mL using Vitrobot without wait time, blot force of −10 and blot time of 2.5 -- 3 s. AMC011FL nanodisc was prepared with lipid ratio 30:23:20:15:10:1:1 (DOPC:DOPS:CHS:DOPE:DOPA:PIP2(4,5):DOPG) and complexed with 10E8 Fab during the final lentil lectin polishing purification step of the nanodisc preparation. Approximately 10 X molar excess of Fab was added to matrix bound nanodiscs, incubated over night at +4°C, and washed extensively with TBS followed by elution, dialysis and concentrating steps as described above for nanodisc assembly. The sample was then frozen on graphene oxide grids (GO on Quantifoils R1.2/1.3, Cu, 400 mesh, Electron Microscopy Sciences) without wait time, blot force of 0, and blot time of 2.5 -- 3 s at 0.1 -- 0.2 mg/mL.

### Electron microscopy imaging and data processing {#sec4.4.8}

Negative stain EM data was collected on a Tecnai Spirit microscope operating at 120 keV using Leginon automated image collection software ([@bib52]). The image collection parameters are summarized in table S1. Cryo-EM data were collected on a Titan Krios and Talos Arctica operating at 300 keV or 200 keV, respectively, both equipped with a K2 direct electron detector (Gatan) using Leginon. Data were processed using various workflows depending on sample type as summarized in [Figures S2-- S4](#mmc1){ref-type="supplementary-material"}. In summary, particles from negative-stain EM data were picked using DogPicker ([@bib72]) and exported to particle stacks using Relion 3.0 ([@bib80]). 2D and 3D classification was done using cryoSPARC2 ([@bib53]). After one or two rounds of 2D classification and selection of particles with bicelle or disc-like features, approximately one reference free ab-initio 3D reconstruction was generated per 10,000 particles. Ab-initio models were then refined using homogeneous refinement option in cryoSPARC2. Cryo-EM data processing was initiated by frame alignment using MotionCor2 ([@bib79]), followed by contrast transfer function (CTF) calculation by GCTF ([@bib77]), particle picking with DogPicker, and extraction with Relion 3.0, or CTF calculation, particle extraction and 2D classification in cryoSPARC2. For detergent-lipid micelle datasets, particle stacks after 2D classification were exported to Relion 3.0 for subsequent processing steps. Here, initial particle coordinates were set by binning all imported particles by 4 and refining them using a 60 Å low-pass filtered Env ectodomain with two copies of PGT151 Fab as the initial model. This initial refinement was then used as a seed for subsequent one to four rounds of 3D classification before unbinning, final refinement, and postprocessing using Relion 3 standard parameters. Multibody refinement was done using the final, postprocessed 3D refinement as the starting model with Relion 3 multibody refinement function ([@bib48]). Nanodisc reconstructions were done in cryoSPARC2. Briefly, after one or two rounds of 2D classification, selected particles were classified using negative-stain reconstructions from the same sample as seed models with heterogeneous refinement function. This process was repeated using prior models as seeds when further classification was needed. Final, clean 3D classes were refined with non-uniform refinement and classes that refined beyond 7Å were postprocessed with local resolution estimation followed by local filtering. Angles between the membrane bilayer, Fab and Env were measures by placing first axis on the surface of the bilayer in EM density map, second axis through the center of the Fab density and fitted Fab structure, and the third through the 3-fold axis of the fitted Env structure. Height from bilayer in all data was estimated as follows. Env ectodomain structure model (e.g., PC64FL -- PDB [6DCQ](pdb:6DCQ){#intref0140}) was placed inside EM map using chimera fit in map -function. Next, a centroid was placed in the center of last modeled residues (Asp664) of three Env protomers. Then, a bilayer modeled with CHARMM-GUI ([@bib30]) was aligned to the EM density corresponding the nanodisc or bicelle. Distance from the centroid to the closest atom in the modeled bilayer was reported as the Env distance from bilayer. All EM data were visualized and analyzed using USCF Chimera and ChimeraX ([@bib20], [@bib50]). Hybrid model of AMC011FL nanodisc in complex with PGT151 Fab and 10E8 Fab was generated and deposited to Protein Data Bank with accession code PDB [6VPX](pdb:6VPX){#interref180}. This model was generated by rigid body fitting separate gp120 and gp41 subunits and PGT151 variable domain of AMC011 FL structure (PDB: [6OLP](pdb:6OLP){#intref0145}), and variable domains of 10E8 Fab with MPER peptide (PDB: [5T80](pdb:5T80){#intref0150}).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Signal normalization and graph presentation of bio-layer interferometry data was performed using GraphPad Prism software as described above.
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